| 000 | 01148 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517151101.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1935-5548 | ||
| 024 | 7 |
_a10.2337/dc17-er06 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKazda, Christof M | |
| 245 | 0 | 0 |
_aErratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249. _h[electronic resource] |
| 260 |
_bDiabetes care _c06 2017 |
||
| 300 |
_a808 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Published Erratum | ||
| 700 | 1 | _aDing, Ying | |
| 700 | 1 | _aKelly, Ronan P | |
| 700 | 1 | _aGarhyan, Parag | |
| 700 | 1 | _aShi, Chunxue | |
| 700 | 1 | _aLim, Chay Ngee | |
| 700 | 1 | _aFu, Haoda | |
| 700 | 1 | _aWatson, David E | |
| 700 | 1 | _aLewin, Andrew J | |
| 700 | 1 | _aLandschulz, William H | |
| 700 | 1 | _aDeeg, Mark A | |
| 700 | 1 | _aMoller, David E | |
| 700 | 1 | _aHardy, Thomas A | |
| 773 | 0 |
_tDiabetes care _gvol. 40 _gno. 6 _gp. 808 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/dc17-er06 _zAvailable from publisher's website |
| 999 |
_c27091814 _d27091814 |
||